{
    "organizations": [],
    "uuid": "23a72a2bdbb3276073ac695f2f6c99e4fa21b218",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-novartis-forms-alliance-for-treati/brief-novartis-forms-alliance-for-treating-infectious-diarrheal-disease-idUSFWN1Q403U",
    "ord_in_thread": 0,
    "title": "BRIEF-Novartis forms alliance for treating infectious diarrheal disease",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 14 (Reuters) - Novartis AG:\n* NOVARTIS FORMS ALLIANCE TO DEVELOP MEDICINES FOR TREATING INFECTIOUS DIARRHEAL DISEASE\n* GETS FUNDING FROM BILL & MELINDA GATES FOUNDATION FOR FURTHER DEVELOPMENT OF DRUG CANDIDATE KDU731 FOR CRYPTOSPORIDIOSISâ€‹ Source text for Eikon: Further company coverage: (Reporting By Michael Shields)\n ",
    "published": "2018-02-14T14:21:00.000+02:00",
    "crawled": "2018-02-15T20:20:12.023+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "novartis",
        "ag",
        "novartis",
        "form",
        "alliance",
        "develop",
        "medicine",
        "treating",
        "infectious",
        "diarrheal",
        "disease",
        "get",
        "funding",
        "bill",
        "melinda",
        "gate",
        "foundation",
        "development",
        "drug",
        "candidate",
        "kdu731",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "reporting",
        "michael",
        "shield"
    ]
}